Last reviewed · How we verify
ET0111
At a glance
| Generic name | ET0111 |
|---|---|
| Sponsor | Etern BioPharma (Shanghai) Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ET0111 CI brief — competitive landscape report
- ET0111 updates RSS · CI watch RSS
- Etern BioPharma (Shanghai) Co., Ltd portfolio CI